Cargando…
In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model
BACKGROUND: Bee venom (BV), a type of toxin extracted from honeybees (Apis mellifera), has been empirically and widely used to treat inflammatory diseases throughout Asia. Essential BV (eBV) was developed by removing phospholipase A2 (PLA2) and histamine to lower occurrence of allergic reaction. Thi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145209/ https://www.ncbi.nlm.nih.gov/pubmed/27930719 http://dx.doi.org/10.1371/journal.pone.0168120 |
_version_ | 1782473256052195328 |
---|---|
author | Chung, Hwa-Jin Lee, Jinho Shin, Joon-Shik Kim, Me-riong Koh, Wonil Kim, Min-Jeong Lee, Jae-woong Kim, Eun Jee Lee, In-Hee Kim, Won Kyung Lee, Yoon Jae Lee, Sang Kook Ha, In-Hyuk |
author_facet | Chung, Hwa-Jin Lee, Jinho Shin, Joon-Shik Kim, Me-riong Koh, Wonil Kim, Min-Jeong Lee, Jae-woong Kim, Eun Jee Lee, In-Hee Kim, Won Kyung Lee, Yoon Jae Lee, Sang Kook Ha, In-Hyuk |
author_sort | Chung, Hwa-Jin |
collection | PubMed |
description | BACKGROUND: Bee venom (BV), a type of toxin extracted from honeybees (Apis mellifera), has been empirically and widely used to treat inflammatory diseases throughout Asia. Essential BV (eBV) was developed by removing phospholipase A2 (PLA2) and histamine to lower occurrence of allergic reaction. This study investigated the anti-allergic and anti-inflammatory activities of eBV in vitro and in vivo and its underlying mechanism of action. METHODS: The anti-inflammatory potential of eBV was assessed in vivo using a carrageenan-induced paw edema model. To further investigate the mechanism by which eBV exerts anti-allergic and anti-inflammatory effects, compound 48/80-stimulated RBL-2H3 cells and lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophage cells were studied in vitro. RESULTS: Release of β-hexosaminidase and histamine was increased by eBV in a dose-dependent manner, but these levels were lower in eBV compared to original BV at the same concentration. In addition, eBV suppressed compound 48/80-induced expression of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in RBL-2H3 cells. eBV was also shown to suppress nitric oxide (NO) production by down-regulating mRNA expression and subsequent protein expression of inflammatory mediators in LPS-induced RAW 264.7 cells. Phosphorylation of activators and signal transducers of transcription 1/interferon regulatory factor 3 (STAT1/IRF3) was attenuated by eBV treatment. eBV significantly inhibited carrageenan-induced acute edema in vivo. Serum levels of prostaglandin E2 (PGE2), TNF-α, and IL-1β were also down-regulated by eBV. CONCLUSIONS: These results demonstrate that eBV inhibits allergic and inflammatory response by reducing inflammatory mediator production via regulation of the STAT1/IRF3 signaling pathway, suggesting that eBV is a feasible candidate for regulation of allergic-inflammatory response in complementary and alternative medicine. |
format | Online Article Text |
id | pubmed-5145209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-51452092016-12-22 In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model Chung, Hwa-Jin Lee, Jinho Shin, Joon-Shik Kim, Me-riong Koh, Wonil Kim, Min-Jeong Lee, Jae-woong Kim, Eun Jee Lee, In-Hee Kim, Won Kyung Lee, Yoon Jae Lee, Sang Kook Ha, In-Hyuk PLoS One Research Article BACKGROUND: Bee venom (BV), a type of toxin extracted from honeybees (Apis mellifera), has been empirically and widely used to treat inflammatory diseases throughout Asia. Essential BV (eBV) was developed by removing phospholipase A2 (PLA2) and histamine to lower occurrence of allergic reaction. This study investigated the anti-allergic and anti-inflammatory activities of eBV in vitro and in vivo and its underlying mechanism of action. METHODS: The anti-inflammatory potential of eBV was assessed in vivo using a carrageenan-induced paw edema model. To further investigate the mechanism by which eBV exerts anti-allergic and anti-inflammatory effects, compound 48/80-stimulated RBL-2H3 cells and lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophage cells were studied in vitro. RESULTS: Release of β-hexosaminidase and histamine was increased by eBV in a dose-dependent manner, but these levels were lower in eBV compared to original BV at the same concentration. In addition, eBV suppressed compound 48/80-induced expression of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in RBL-2H3 cells. eBV was also shown to suppress nitric oxide (NO) production by down-regulating mRNA expression and subsequent protein expression of inflammatory mediators in LPS-induced RAW 264.7 cells. Phosphorylation of activators and signal transducers of transcription 1/interferon regulatory factor 3 (STAT1/IRF3) was attenuated by eBV treatment. eBV significantly inhibited carrageenan-induced acute edema in vivo. Serum levels of prostaglandin E2 (PGE2), TNF-α, and IL-1β were also down-regulated by eBV. CONCLUSIONS: These results demonstrate that eBV inhibits allergic and inflammatory response by reducing inflammatory mediator production via regulation of the STAT1/IRF3 signaling pathway, suggesting that eBV is a feasible candidate for regulation of allergic-inflammatory response in complementary and alternative medicine. Public Library of Science 2016-12-08 /pmc/articles/PMC5145209/ /pubmed/27930719 http://dx.doi.org/10.1371/journal.pone.0168120 Text en © 2016 Chung et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Chung, Hwa-Jin Lee, Jinho Shin, Joon-Shik Kim, Me-riong Koh, Wonil Kim, Min-Jeong Lee, Jae-woong Kim, Eun Jee Lee, In-Hee Kim, Won Kyung Lee, Yoon Jae Lee, Sang Kook Ha, In-Hyuk In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model |
title | In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model |
title_full | In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model |
title_fullStr | In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model |
title_full_unstemmed | In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model |
title_short | In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model |
title_sort | in vitro and in vivo anti-allergic and anti-inflammatory effects of ebv, a newly developed derivative of bee venom, through modulation of irf3 signaling pathway in a carrageenan-induced edema model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145209/ https://www.ncbi.nlm.nih.gov/pubmed/27930719 http://dx.doi.org/10.1371/journal.pone.0168120 |
work_keys_str_mv | AT chunghwajin invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT leejinho invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT shinjoonshik invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT kimmeriong invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT kohwonil invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT kimminjeong invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT leejaewoong invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT kimeunjee invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT leeinhee invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT kimwonkyung invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT leeyoonjae invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT leesangkook invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel AT hainhyuk invitroandinvivoantiallergicandantiinflammatoryeffectsofebvanewlydevelopedderivativeofbeevenomthroughmodulationofirf3signalingpathwayinacarrageenaninducededemamodel |